BBWI240705P42000
- 3.00
- -0.09-2.91%
Bath & Body Works Newsroom
Bath & Body Works Analyst Ratings
BMO Capital Maintains Outperform on Bath & Body Works, Raises Price Target to $55
Goldman Sachs Adjusts Price Target on Bath & Body Works to $60 From $56, Keeps Buy Rating
Piper Sandler Adjusts Bath & Body Works' Price Target to $47 From $45, Keeps Neutral Rating
Bath & Body Works Analyst Ratings
Telsey Advisory Group Maintains Outperform on Bath & Body Works, Maintains $53 Price Target
Telsey Advisory Sticks to Their Buy Rating for Bath & Body Works (BBWI)
Telsey Advisory Group Maintains Outperform on Bath & Body Works, Maintains $53 Price Target
Bath & Body Works Analyst Ratings
Deutsche Bank Raises Price Target on Bath & Body Works to $57 From $53
Komo: The Bath & Body Works (BBWI.US) rating was raised from reduced holdings to a neutral rating, and the target price was adjusted from $40.00 to $53.00.
Bath & Body Works Analyst Ratings
JPMorgan Upgrades Bath & Body Works to Neutral From Underweight, Adjusts Price Target to $53 From $40
Morgan Stanley Raises Price Target on Bath & Body Works to $56 From $52, Adds 'Top Pick' Label, Keeps Overweight Rating
Bath & Body Works Analyst Ratings
Analysts Offer Insights on Consumer Cyclical Companies: Wayfair (W), General Motors (GM) and Bath & Body Works (BBWI)
Piper Sandler: Maintaining the Bath & Body Works (BBWI.US) rating, adjusted from neutral to neutral, and adjusted the target price from $44.00 to $45.00.
Bath & Body Works Analyst Ratings
Piper Sandler Keeps Their Hold Rating on Bath & Body Works (BBWI)
Bath & Body Works Analyst Ratings